|
|
|
 |   | BioMed Central home | Journals A-Z | Feedback | My details |
| Thematic SeriesThe Global Pharmaceutical Market and Generic Drugs: Policy Challenges for AustraliaEdited by Simon Barraclough (deputy editor) and Dr Hans Lofgren, from the School of International and Political Studies, Deakin University Victoria
Commentary
 Reshaping Australian drug policy: the dilemmas of generic medicines policy Hans Löfgren Australia and New Zealand Health Policy 2007, 4:11 (1 June 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Research The global biopharma industry and the rise of Indian drug multinationals: implications for Australian generics policy Hans Löfgren Australia and New Zealand Health Policy 2007, 4:10 (1 June 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Debate Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal Thomas A Faunce Australia and New Zealand Health Policy 2007, 4:9 (1 June 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Debate 'Linkage' pharmaceutical evergreening in Canada and Australia Thomas A Faunce, Joel Lexchin Australia and New Zealand Health Policy 2007, 4:8 (1 June 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Commentary  Generic drug policy in Australia: a community pharmacy perspective Grahame Beecroft Australia and New Zealand Health Policy 2007, 4:7 (1 June 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] | |||
 | |
|
|
| © 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media. |